04/2017-Test, Article and Evaluation
|
Financial/Commercial Relationships
DISCLOSURES:
Reviewer 1- Nothing to Disclose
Reviewer 2- Nothing to Disclose
Associate Editor-Honoraria from: Takeda, Genoptix and GI Therapeutics.
Editor- in Chief- Nothing to Disclose.
Author- Research Grant from: ROCHE
CME Editor- Advisory Board/Honoraria for: AstraZeneca, Lilly, Roche; Research Grants from: Genzyme, Boehringer Ingelheiml.
Planner- Nothing to Disclose
Reviewer 1- Nothing to Disclose
Reviewer 2- Nothing to Disclose
Associate Editor-Honoraria from: Takeda, Genoptix and GI Therapeutics.
Editor- in Chief- Nothing to Disclose.
Author- Research Grant from: ROCHE
CME Editor- Advisory Board/Honoraria for: AstraZeneca, Lilly, Roche; Research Grants from: Genzyme, Boehringer Ingelheiml.
Planner- Nothing to Disclose